Guenther L - Search Results

1

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.

Papp KA, Guenther L, Boyden B, Larsen FG, Harvima RJ, Guilhou JJ, Kaufmann R, Rogers S, van de Kerkhof PC, Hanssen LI, Tegner E, Burg G, Talbot D, Chu A. Papp KA, et al. Among authors: guenther l. J Am Acad Dermatol. 2003 Jan;48(1):48-54. doi: 10.1067/mjd.2003.130. J Am Acad Dermatol. 2003. PMID: 12522370 Clinical Trial.

2

Tazarotene combination treatments in psoriasis.

Guenther L. Guenther L. J Am Acad Dermatol. 2000 Aug;43(2 Pt 3):S36-42. doi: 10.1067/mjd.2000.108320. J Am Acad Dermatol. 2000. PMID: 10898828 Review.

3

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Guenther LC, Poulin YP, Pariser DM. Guenther LC, et al. Clin Ther. 2000 Oct;22(10):1225-38. doi: 10.1016/s0149-2918(00)83065-9. Clin Ther. 2000. PMID: 11110233 Clinical Trial.

4

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.

Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, Garcia-Diez A, Springborg J. Guenther L, et al. Br J Dermatol. 2002 Aug;147(2):316-23. doi: 10.1046/j.1365-2133.2002.04967.x. Br J Dermatol. 2002. PMID: 12174105 Clinical Trial.

5

Optimizing treatment with topical tazarotene.

Guenther LC. Guenther LC. Am J Clin Dermatol. 2003;4(3):197-202. doi: 10.2165/00128071-200304030-00006. Am J Clin Dermatol. 2003. PMID: 12627995 Review.

6

Fixed-dose combination therapy for psoriasis.

Guenther LC. Guenther LC. Am J Clin Dermatol. 2004;5(2):71-7. doi: 10.2165/00128071-200405020-00001. Am J Clin Dermatol. 2004. PMID: 15109271 Review.

7

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

8

Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).

Guenther LC. Guenther LC. Skin Therapy Lett. 2009 May;14(4):1-4. Skin Therapy Lett. 2009. PMID: 19585059 Free article.

9

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, Kerrouche N, Villemagne H; CalePso Study Team. Poulin Y, et al. Among authors: guenther l. Cutis. 2010 Jan;85(1):43-50. Cutis. 2010. PMID: 20184211 Clinical Trial.

10

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.

Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L. Fleming C, et al. Among authors: guenther l. Eur J Dermatol. 2010 Jul-Aug;20(4):465-71. doi: 10.1684/ejd.2010.0948. Epub 2010 Apr 23. Eur J Dermatol. 2010. PMID: 20413372 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page